| Authors: |
Pender A; Lung Cancer Group, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom; Department of Medicine, The Royal Marsden NHS Foundation Trust, London, United Kingdom; The Francis Crick Institute, London, United Kingdom., Garcia-Murillas I; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Rana S; Lung Cancer Group, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom., Cutts RJ; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Kelly G; The Francis Crick Institute, London, United Kingdom., Fenwick K; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Kozarewa I; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Gonzalez de Castro D; The Centre for Molecular Pathology, The Institute of Cancer Research, Sutton, United Kingdom., Bhosle J; Department of Medicine, The Royal Marsden NHS Foundation Trust, London, United Kingdom., O'Brien M; Department of Medicine, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Turner NC; Department of Medicine, The Royal Marsden NHS Foundation Trust, London, United Kingdom; The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Popat S; Department of Medicine, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Downward J; Lung Cancer Group, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom; The Francis Crick Institute, London, United Kingdom. |
